Stock search

Ticker or company name

ZBH card

ZBH price forecast

Zimmer Biomet$101,41

P/E now is 25,6. Average over 5 years: 47,0 (range 24–65). The stock is 45% below its history.

Base · FY2030

$202,60+18,9% a year

The base case gives 18,9% a year, above your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$8,50 bn$8,77 bn$9,05 bn$9,34 bn$9,65 bn
Net income$725 m$748 m$772 m$797 m$823 m
EPS$3,68$3,83$3,98$4,14$4,31

Changed values are highlighted. Bear and bull cases: growth ∓ 8,8%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $101,41

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$49,71

Price change
−51,0%
A year
−14,9%
Fair value today
$35,29
Margin of safety
−65,2%

Base$202,60

Price change
+99,8%
A year
+18,9%
Fair value today
$139,87
Margin of safety
+37,9%

Bull$519,12

Price change
+411,9%
A year
+49,2%
Fair value today
$355,58
Margin of safety
+250,6%

What growth the price implies

For the stock to return 10% a year, revenue must grow −2,8% a year to FY2030 at a 8,5% margin and P/E 47,0.

Growth over 5 years
3,2%
Analyst consensus
no data
In your model
3,2%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$202,60+18,9% a year